In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases

Methods in Molecular Biology

Volumn 414, Issue , 2007, Pages 109-135

  Lee, Brian W ^a   Olin, Michael R ^a   Johnson, Gary L ^a   Griffin, Robert J ^a  

^a NONE

Author keywords

Apoptosis; Caspase; Cytotoxicity assay; Detection; FLICA; In vitro; In vivo; Tumor imaging

Indexed keywords

CASPASE; CYTOTOXIN; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ANIMAL; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CULTURE TECHNIQUE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METHODOLOGY; PHYSIOLOGY; TOXICITY TESTING;

ANIMALS; APOPTOSIS; CASPASES; CELL CULTURE TECHNIQUES; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CYTOTOXINS; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MODELS, BIOLOGICAL; TOXICITY TESTS;

ANIMALIA; MUS; RATTUS;

EID: 37849005392     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (56)

1. Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
2. Wyllie, A.H., Kerr, J.F.R., and Currie, A.R. (1981) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
3. Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H. (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424.
4. Nicholson, D.W. (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042.
5. Heemels, M.T. (ed.) (2000) Nature insight apoptosis. Nature 407, 770-816.
6. Degterev, A., Boyce, M., and Yuan, J. (2003) A decade of caspases. Oncogene 22, 8543-8567.
7. Fink, S.L. and Cookson, B.T. (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907-1916.
8. Lavrik, I.N., Golks, A., and Krammer, P.H. (2005) Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115, 2665-2672.
9. Thornberry, N.A. and Lazebnik, Y. (1998) Caspases: enemies within. Science 281, 1312-1316.
10. Thornberry, N.A. et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1ß processing in monocytes. Nature 356, 768-774.
11. Thornberry, N.A. et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272, 17907-17911.
12. Fuentes-Prior, P. and Salvesen, G.S. (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384, 201-232.
13. Sarin, A., Wu, M.L., and Henkart, P.A. (1996) Different interleukin-1ß converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184, 2445-2450.
14. Armstrong, R.C. et al. (1996) Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 211, 16850-16855.
15. Garcia-Caivo, M., Peterson, E.P., Leiting, B., Ruel, R., Nicholson, D.W., and Thornberry, N.A. (1998) Inhibition of human caspases by peptide-based macro-molecular inhibitors. J. Biol. Chem. 273, 32608-32613.
16. Sun, X.M., MacFarlane, M., Zhuang, J., Wolf, B.B., Green, D.R., and Cohen, G.M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053-5060.
17. Ekert, P.G., Silke, J., and Vaux, D.L. (1999) Caspase inhibitors. Cell Death Differ. 6, 1081-1086.
18. Clark, P., Dziarmaga, A., Eccles, M., and Goodyer, P. (2004) Rescue of defective branching nephrogenesis in renal coloboma syndrome by the caspase inhibitor, z-VAD-FMK. J. Am. Soc. Nephrol. 15, 299-305.
19. Nakano, M. et al. (2004) Caspase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves islet graft function. Pancreas 29, 104-109.
20. Nedev, H.N., Klaiman, G., LeBlanc, A., and Saragovi, H.U. (2005) Synthesis and evaluation of novel dipeptidyl benzoyloxymethyl ketones as caspase inhibitors. Biochem. Biophys. Res. Commun. 336, 397-400.
21. Rauber, P., Angliker, , Walker, B., and Shaw, E. (1986) The synthesis of peptidylfluoromethanes and their properties as inhibitors of serine proteases and cysteine proteases. Biochem, J. 239, 633-640.
22. Powers, J.C., Asgian, J.L., Ekici, O.D., and James, K.E. (2002) Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem. Rev. 102, 4639-4750.
23. Wu, J.C. and Fritz, L.C. (1999) Irreversible caspase inhibitors: tools for studying apoptosis. Methods 17, 320-328.
24. Bedner, E., Smolewski, P., Amstad, P., and Darzynkiewicz, Z. (2000) Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp. Cell Res. 259, 308-313.
25. Amstad, P.A., Yu, G.L., Johnson, G.L., Lee, B.L., Dhawan, S., and Phelps, D.J. (2001) Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors. Biotechniques 31, 608-616.
26. Smolewski, P., Bedner, E., Du, L., Hsieh, T.C., Wu, J.M., Phelps, D.J., and Darzynkiewicz, Z. (2001) Detection of caspase activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 44, 73-82.
27. Smolewski, P., Grabarek, J., Halicka, H.D., and Darzynkiewicz, Z. (2002) Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis. J. Immunol. Methods 265, 111-121.
28. Smolewski, P., Grabarek, J., Lee, B.W., Johnson, G.L., and Darzynkiewicz, Z. (2002) Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-a or camptothecin assayed by the stathmo-apoptosis method. Cytometry 47, 143-149.
29. Wolbers, F., Buijtenhuljs, P., Haanen, C., and Vermes, I. (2004) Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis 9, 385-392.
30. Grunewald, S., Paasch, U., Said, T.M., Sharma, R.K., Glander, H.J., and Agarwal, A. (2004) Caspase activation in human spermatozoa in response to physiological and pathological stimuli. Fertil. Steril. 83, 1106-1112.
31. Fiala, M., Lin, J., Ringman, J., Arab, V.K., Tsao, A., Patel, A., Lossinsky, A.S., Graves, M.C., Gustavson, A., Sayre, J., Sofroni, E., Suarez, T., Chiappelli, F., and Bernard, G. (2005) Ineffective phagocytosis of amyloid-B by macrophages of Alzheimer's disease patients. J. Alzheimer Dis. 7, 221-232.
32. Mizukami, S., Kikuchi, K., Higuchi, T., Urano, Y., Mashima, T., Tsuruo, T., and Nagano, T. (1999) Imaging of caspase-3 activation in HeLa cells stimulated with etoposide using a novel fluorescent, probe. FEBS Lett. 453, 356-360.
33. Hug, H., Los, M., Hirt, W., and Debatin, K.M. (1999) Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry 38, 13906-13911.
34. Mack, A., Purinarm, C., and Hacker, G. (2000) Detection of caspase-activation in intact lymphoid cells using standard caspase substrates and inhibitors. J. Immunol. Methods 241, 19-31.
35. Komoriya, A., Packard, B.Z., Brown, M.J., Wu, M.L., and Henkart, P.A. (2000) Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic substrates. J. Exp. Med. 191, 1819-1828.
36. Telford, W.G., Komoriya, A., and Packard, B.Z. (2002) Detection of localized caspase activity in early apoptotic cells by laser scanning cytometry. Cytometry 47, 81-88.
37. Lee, B.W., Johnson, G.L., Hed, S.A., Darzynkiewicz, Z., Talhouk, J.W., and Mehrotra, S. (2003) DEVDase detection in intact apoptotic cells using the cell permeant fluorogenic substrate, (z-DEVD)2-cresyl violet. Biotechniques 35, 1080-1085.
38. Li, X., Du, L., and Darzynkiewicz, Z. (2000) During apoptosis of HL-60 and U-937 cells caspases are activated independently of dissipation of mitochondrial electrochemical potential. Exp. Cell Res. 257, 290-297.
39. Duan, R.W., Garner, D.S., Williams, S.D., Funckes-Shippy, C.L., Spath, I.S., and Blomme, E.A. (2003) Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J. Pathol. 199, 221-228.
40. Salvioli, S., Ardizzoni, A., Franceschi, C., and Cossarizza, A. (1997) JC-1 but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 411, 77-82.
41. Poot, M., Zhang, Y.Z., Kramer, J.A., Wells, K.S., Jones, L.J., Hanzel, D.K., Lugade, A.G., Singer, V.L., and Haugland, R.P. (1996) Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J. Histochem. Cytochem. 44, 1363-1372.
42. Brunner, K.T., Mauel, J., Cerottini, J.C., and Chapuis, B. (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labeled allogenic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14, 181-196.
43. Ward, P.W., Bonaparte, M.I., and Barker, E. (2004) HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS 18, 1769-1779.
44. Barber, D.L., Wherry, E.J., and Ahmed, R. (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171, 27-31.
45. Yang, S. and Haluska, F.G. (2004) Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. J. Immunol. 172, 4599-4608.
46. Schwarer, A.P., Jiang, Y.Z., Deacock, S., Brookes, P.A., Barret, A.J., Goldman, J.M., Batchlor, J.R., and Lechler, R.I. (1994) Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation. Transplantation 58, 1198-1203.
47. Russell, J.H. and Ley, T.J. (2002) Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20, 323-370.
48. Pross, H., Callewaert, D., and Rubin, P. (1986) Assays for NK cell cytotoxicity-their values and pitfalls, in Immunobiology of Natural Killer Cells (E. Lotzova and R.B. Herberman eds.) Vol, I. CRC Press, Boca Raton, FL, pp. 1-16.
49. Jerome, K.R., Sloan, D.D., and Aubert, M. (2003) Measurement of CTL-induced cytotoxicity: the caspase 3 assay. Apoptosis 8, 563-571.
50. Slezak, S.E. and Horan, P.K. (1989) Cell-mediated cytotoxicity: a highly sensitive and informative flow cytometric assay. J. Immunol. Methods 117, 205-214.
51. Radosevic, K., Garritsen, H.S.P., Van Graft, M., De Grooth, B.G., and Greve, J. (1990) A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells. J. Immunol. Methods 135, 81-89.
52. Hatam, L., Schuval, S., and Bonagura, V.R. (1994) Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry 16, 59-68.
53. Lee-MacAry, A.E., Ross, E.L., Davies, D., Laylor, R., Honeychurch, J., Glennie, M.J., Snary, D., and Wilkinson, R.W. (2001) Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J. Immunol. Methods 252, 83-92.
54. Hoppner, M., Luhm, J., Schlenke, P., Koritke, P., and Frohn, C. (2002) A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J. Immunol. Methods 267, 157-163.
55. Olin, M.R., Choi, K.H., Lee, J., and Molitor, T.W. (2005) γδ T-lymphocyte cytotoxic activity against Mycobacterium bovis analyzed by flow cytometry. J. Immunol. Methods 297, 1-11.
56. Kienzle, N., Oliver, S., Buttigieg, K., and Kelso, A. (2002) The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers. J. Immunol. Methods 267, 98-108.